Condition: Carcinoma, Non-Small-Cell Lung Cancer · Bone Metastases From Solid Tumors · Sponsor: Kiromic BioPharma Inc.
This is a clinical trial studying intravenous infusions of allogeneic gamma delta T cells after receiving low dose radiotherapy in participants with locally advanced or metastatic non-small cell lung cancer or solid tumors with bone metastases to evaluate the safety and efficacy of combining immunotherapy with radiation therapy.
This description comes directly from the study's public registry record.
Matthew Wagener, BS · 1-844-539-2873 · mwagener@kiromic.com
Leonardo Mirandola, PhD · 1-844-539-2873 · lmirandola@kiromic.com
Always discuss trial participation with your own doctor first.
| The University of Arizona Cancer Center | Tucson, Arizona, United States | Not Yet Recruiting |
| Beverly Hills Cancer Center | Beverly Hills, California, United States | Recruiting |
| UPMC Hillman Cancer Center | Pittsburgh, Pennsylvania, United States | Recruiting |
| Texas Oncology - Tyler | Tyler, Texas, United States | Recruiting |
| Virginia Oncology Associates | Norfolk, Virginia, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06069570